Tove Kirkegaard
Tove Kirkegaard
Kirurgisk Afdeling, Køge og Roskilde Sygehus, Forskningskoordinator
Bekræftet mail på tovekirkegaard.dk
TitelCiteret afÅr
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard, CJ Witton, LM McGlynn, SM Tovey, B Dunne, A Lyon, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
2962005
Plasminogen activator inhibitor-1 represses integrin-and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
L Kjøller, SM Kanse, T Kirkegaard, KW Rodenburg, E Rønne, ...
Experimental cell research 232 (2), 420-429, 1997
2691997
Proteinases in bone resorption: obvious and less obvious roles
JM Delaissé, MT Engsig, V Everts, M del Carmen Ovejero, M Ferreras, ...
Clinica Chimica Acta 291 (2), 223-234, 2000
2422000
Observer variation in immunohistochemical analysis of protein expression, time for a change?
T Kirkegaard, J Edwards, S Tovey, LM McGlynn, SN Krishna, ...
Histopathology 48 (7), 787-794, 2006
2082006
Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease
J Brynskov, P Foegh, G Pedersen, C Ellervik, T Kirkegaard, A Bingham, ...
Gut 51 (1), 37-43, 2002
1912002
Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease
J Brynskov, P Foegh, G Pedersen, C Ellervik, T Kirkegaard, A Bingham, ...
Gut 51 (1), 37-43, 2002
1912002
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease
T Kirkegaard, A Hansen, E Bruun, J Brynskov
Gut 53 (5), 701-709, 2004
1842004
Transforming growth factor-β controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression
MA Karsdal, P Hjorth, K Henriksen, T Kirkegaard, KL Nielsen, H Lou, ...
Journal of Biological Chemistry 278 (45), 44975-44987, 2003
1552003
A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells
TL Andersen, M del Carmen Ovejero, T Kirkegaard, T Lenhard, NT Foged, ...
Bone 35 (5), 1107-1119, 2004
1472004
Amplified in breast cancer 1 in human epidermal growth factor receptor–positive tumors of tamoxifen-treated breast cancer patients
T Kirkegaard, LM McGlynn, FM Campbell, S Müller, SM Tovey, B Dunne, ...
Clinical Cancer Research 13 (5), 1405-1411, 2007
1372007
Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption
P Hou, T Troen, MC Ovejero, T Kirkegaard, TL Andersen, I Byrjalsen, ...
Bone 34 (1), 37-47, 2004
1072004
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients
LM McGlynn, T Kirkegaard, J Edwards, S Tovey, D Cameron, C Twelves, ...
Clinical cancer research 15 (4), 1487-1495, 2009
842009
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH
T Kirkegaard, CJ Witton, J Edwards, KV Nielsen, LB Jensen, ...
Histopathology 56 (2), 203-211, 2010
622010
Kinetic analysis of integrin‐dependent cell adhesion on vitronectin: The inhibitory potential of plasminogen activator inhibitor‐1 and RGD peptides
M Germer, SM Kanse, T Kirkegaard, L Kjøller, B Felding‐Habermann, ...
European journal of biochemistry 253 (3), 669-674, 1998
591998
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon, R Rodseth, BM Biccard, ...
The Lancet 391 (10137), 2325-2334, 2018
522018
Bad expression predicts outcome in patients treated with tamoxifen
E Cannings, T Kirkegaard, SM Tovey, B Dunne, TG Cooke, JMS Bartlett
Breast cancer research and treatment 102 (2), 173-179, 2007
512007
Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium
G Pedersen, T Saermark, T Kirkegaard, J Brynskov
Clinical & Experimental Immunology 155 (2), 257-265, 2009
502009
A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells
S Thrane, AM Pedersen, MBH Thomsen, T Kirkegaard, BB Rasmussen, ...
Oncogene 34 (32), 4199, 2015
372015
Genetic alterations of CCND1 and EMSY in breast cancers
T Kirkegaard, KV Nielsen, LB Jensen, FM Campbell, S Müller, SM Tovey, ...
Histopathology 52 (6), 698-705, 2008
372008
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer
CL Alves, D Elias, M Lyng, M Bak, T Kirkegaard, AE Lykkesfeldt, HJ Ditzel
Clinical cancer research 22 (22), 5514-5526, 2016
342016
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20